MedPath

RANBAXY (MALAYSIA) SDN. BHD.

🇲🇾Malaysia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

78

HSA:74
NPRA:4

Drug Approvals

CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG

Approval Date
Nov 15, 2024
HSA

CILENTRA 10 ESCITALOPRAM OXALATE TABLET USP 10MG

Approval Date
Nov 15, 2024
HSA

ILUMYA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/ML

Approval Date
Sep 4, 2024
HSA

MAXGALIN 150 CAPSULES 150MG

Approval Date
Sep 15, 2023
HSA

MAXGALIN 75 CAPSULES 75MG

Approval Date
Sep 15, 2023
HSA

MAXGALIN 50 CAPSULES 50MG

Approval Date
Sep 15, 2023
HSA

NIBINASE HARD GELATIN CAPSULE 12.5MG

Approval Date
Mar 24, 2023
HSA

NIBINASE HARD GELATIN CAPSULE 50MG

Approval Date
Mar 24, 2023
HSA

NIBINASE HARD GELATIN CAPSULE 25MG

Approval Date
Mar 24, 2023
HSA

ENTECA FILM COATED TABLET 0.5MG

Approval Date
Sep 12, 2022
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.